Results vary by starting weight, metabolism, adherence, and dose
An FDA database analysis shows that reported adverse skin events after GLP-1 receptor agonist use are rare but can include rash and pruritus, highlighting a need for further research, according to a study
62: 173-81, 2005 [ Links ] 88
Its worth understanding what GLP-1 patches actually contain, whether the science supports them, and what the clinically proven alternatives are
Shifting CrAT activity towards the production of acetylcarnitine may rescue beta-oxidation by increasing free CoA, but it only partially solves problems of energy deficiency because the acetyl groups do not enter the Krebs cycle for energy production, but rather escape from the mitochondria in the form of acetylcarnitine